Professor Dr. Shamshad Zarina

2023 Haneef K, Salim A, Hashim Z, Ilyas A, Syed B, Ahmed A, Zarina S (2023) Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. Appl Biochem Biotechnol.
2023 Tanveer F, Ilyas A, Syed B, Hashim Z, Ahmed A, Zarina S (2023) Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach. Appl Biochem Biotechnol.
2022 Fazal, Y., Zohaib, M., Syed, B., Ansari, S. H., Hashim, Z., Ahmed, A., & Zarina, S. (2022). Prenatal diagnosis of maternal serum from mothers carrying β‐thalassemic fetus. Pediatrics International64(1), e14999.
2021 Mohsin, A., Haneef, K., Ilyas, A., Zarina, S., & Hashim, Z. (2021). Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein and Peptide Letters28(12), 1323-1329.
2021 Usman, M., Ilyas, A., Syed, B., Hashim, Z., Ahmed, A., & Zarina, S. (2021). Serum HSP90-alpha and oral squamous cell carcinoma: a prospective biomarker. Protein and Peptide Letters28(10), 1157-1163.
2020 Hashim, Z., Ilyas, A., & Zarina, S. (2020). Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International19(3), 258-265.
2020 Syed, N., Ilyas, A., Idrees, F., Zarina, S., & Hashim, Z. (2020). Inhibition of USP2 Induces apoptosis through down regulation of fatty acid synthase and Cyclin D1 in triple negative breast cancer. Current Proteomics17(5), 425-432.
2020 Usman, M., Ilyas, A., Hashim, Z., & Zarina, S. (2020). Identification of GIMAP7 and Rabl3 as putative biomarkers for oral squamous cell carcinoma through comparative proteomic approach. Pathology & Oncology Research26(3), 1817-1822.
2020 Malik, U. U., Siddiqui, I. A., Ilyas, A., Hashim, Z., Staunton, L., Kwasnik, A., … & Zarina, S. (2020). Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from Oral squamous cell carcinoma. Pathology & Oncology Research26(3), 1489-1497.
2020 Usman, M., Tanveer, F., Ilyas, A., & Zarina, S. (2020). Varlitinib Mediates Its Activity Through Down Regulating MAPK/EGFR Pathway in Oral Cancer. Current Proteomics17(1), 51-58.
2020 Anwar, M. F., Khalid, R., Hasanain, A., Naeem, S., Zarina, S., Abidi, S. H., & Ali, S. (2020). Integrated cheminformatics-molecular docking approach to drug discovery against viruses. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders)20(2), 150-159.
2019 Basharat, A. R., Iman, K., Khalid, M. F., Anwar, Z., Hussain, R., Kabir, H. G., … & Chaudhary, S. U. (2019). BIRL/SPECTRUM: A MATLAB Toolbox for Proteoform Identification from Top-Down Proteomics Data. Sci Rep, 9(1), 11267.
2019 Syed, N., Ilyas, A., Zarina, S., & Hashim, Z. (2019). Assessment of Anticancer Effect of Alendronate in Breast Cancer: An In vitro Study. J. Biotech. Biomed. Sci, 2(2), 1-7.
2019 Baig, A., Rehman, A. U., & Zarina, S. (2019). Association of PON2 and PON3 polymorphism with risk of developing cataract. Saudi Journal of Ophthalmology33(2), 153-158.
2019 Zohaib, M., Ansari, S. H., Shamsi, T. S., Zubarev, R. A., & Zarina, S. (2019). Pharmacoproteomics profiling of plasma from β‐thalassemia patients in response to hydroxyurea treatment. The Journal of Clinical Pharmacology59(1), 98-106.
2018 Anwar, M. F., Zarina, S., Ali, S., & Abidi, S. H. (2018). Two for one: Viral helicases as an ideal target for HIV and HCV co-infection. Medical Hypotheses116, 139-140.
2018 Ilyas, A., Hashim, Z., Channa, I. S., & Zarina, S. (2018). Alendronate and FTI-277 combination as a possible therapeutic approach for hepatocellular carcinoma: An in vitro study. Hepatobiliary & Pancreatic Diseases International17(3), 241-250.
2018 Siddiqui, S., Anwar, M. F., Naeem, S., Abidi, S. H., Zarina, S., & Ali, S. (2018). Simian virus 40 large T antigen as a model to test the efficacy of flouroquinolones against viral helicases. Bioinformation14(2), 75.
2017 Lateef, M., Azhar, A., Siddiqui, B. S., Zarina, S., Anwar, M. F., Siddiqui, K., … & Perveen, S. (2017). New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies. Heliyon3(7), e00350.
2017 Naseeb, U., Zarina, S., Jägerbrink, T., Shafqat, J., Jörnvall, H., & Axelsson, J. (2017). Differential hemoglobin A sequestration between hemodialysis modalities. Biomolecular Concepts8(2), 125-129.
2016 Waheed, H., Friedman, H., Moin, S. F., Zarina, S., & Ahmed, A. (2016). The Primary Structure of βI-Chain of Hemoglobin from Snake Sindhi Krait (Bungarus sindanus sindanus). The Protein Journal35(3), 193-201.
2016 Atta, A., Ilyas, A., Hashim, Z., & Zarina, S. (2016). Structure Function Relationship of Lactate Dehydrogenase/[epsilon]-Crystallin from Lenses of Indian Spiny-Tailed Lizard (Uromastyx hardwickii). Pakistan Journal of Zoology48(4), 1147-1153.
2016 Atta, A., Hashim, Z., & Zarina, S. (2016). Lens proteomics: exploring adaptive conflict in Uromastyx hardwickii lens proteins. JAPS: Journal of Animal & Plant Sciences26(1), 261-268.
2016 Malik, U. U., Zarina, S., & Pennington, S. R. (2016). Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics. Archives of oral biology63, 53-65.
2016 Baig, A., Zohaib, M., Rehman, A. U., & Zarina, S. (2016). Q192R paraoxonase1 polymorphism is a risk factor for cataract in Pakistani population. Pakistan journal of pharmaceutical sciences29(3), 765-771.
2016 Zohaib, M., Ansari, S. H., Hashim, Z., Shamsi, T. S., & Zarina, S. (2016). Serum Paraoxonase Activity and Malondialdehyde Serum Concentrations Remain Unaffected in Response to Hydroxyurea Therapy in β‐Thalassemia Patients. The Journal of Clinical Pharmacology56(7), 869-874.
2016 Atta, A., Ilyas, A., Hashim, Z., & Zarina, S. (2016). Structure Function Relationship of Lactate Dehydrogenase/[epsilon]-Crystallin from Lenses of Indian Spiny-Tailed Lizard (Uromastyx hardwickii). Pakistan Journal of Zoology48(4), 1147-1153.
2015 Naseeb, U., Axelsson, J., Jägerbrink, T., Shafqat, J., Zarina, S., & Jörnvall, H. (2015). Complementary LC-MS/MS proteomic analysis of uremic plasma proteins. J Coll Physicians Surg Pak25(8), 606-609.
2015 Ilyas, A., Hashim, Z., & Zarina, S. (2015). Effects of 5′-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective. Molecular and Cellular Biochemistry405(1), 53-61.
2014 Malik, U. U., Siddiqui, I. A., Hashim, Z., & Zarina, S. (2014). Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clinica Chimica Acta, 430, 38-42.
2014 Dawood, S., Zarina, S., & Bano, S. (2014). Docking studies of antidepressants against single crystal structure of tryptophan 2, 3-dioxygenase using Molegro Virtual Docker software. Pak J Pharm Sci27(5), 1529-39.
2014 Ilyas, A., Hashim, Z., Naeem, N., Haneef, K., & Zarina, S. (2014). The effect of alendronate on proteome of hepatocellular carcinoma cell lines. International Journal of proteomics, 2014, 0-9.
2013 Siddiqui, S., Khan, I., Zarina, S., & Ali, S. (2013). Use of the SYBR Green dye for measuring helicase activity. Enzyme and microbial technology52(3), 196-198.
2012 Hashim, Z., & Zarina, S. (2012). Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. Journal of diabetes and its complications26(4), 275-279.
2012 Saleem, A., Azam, S. S., & Zarina, S. (2012). Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1. European Biophysics Journal41(2), 241-248.
2011 Hashim, Z., & Zarina, S. (2011). Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age33(3), 377-384.
2010 Ul-Haq, Z., Khan, W., Zarina, S., Sattar, R., & Moin, S. T. (2010). Template-based structure prediction and molecular dynamics simulation study of two mammalian Aspartyl-tRNA synthetases. Journal of molecular graphics and Modelling28(5), 401-412.
2009 Hashim, Z., Ilyas, A., Saleem, A., Salim, A., & Zarina, S. (2009). Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radical Biology and Medicine46(8), 1089-1095.
2008 Naseeb, U., Shafqat, J., Jägerbrink, T., Zarina, S., Alvestrand, A., Jörnvall, H., & Axelsson, J. (2008). Proteome patterns in uremic plasma. Blood purification26(6), 561-568.
2007 Hashim, Z., & Zarina, S. (2007). Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Clinical biochemistry40(9-10), 705-709.
2006 Hashim, Z., & Zarina, S. (2006). Antioxidant markers in human senile and diabetic cataractous lenses. J Coll Physicians Surg Pak16(10), 637-640.
2004 Zarina, S., & Zaidi, Z. H. (2004). Homology modeling of ρ-crystallin from bullfrog (Rana catesbeiana) lens. Journal of Molecular Graphics and Modelling22(4), 285-291.
2002 Thampi, P., Zarina, S., & Abraham, E. C. (2002). α-Crystallin chaperone function in diabetic rat and human lenses. Molecular and cellular biochemistry229(1), 113-118.
2000 Zarina, S., Zhao, H. R., & Abraham, E. (2000). Advanced glycation end products in human senile and diabetic cataractous lenses. Molecular and Cellular Biochemistry210(1), 29-34.
1994 Zarina, S., Zaidi, Z. H., Driessen, H., Srinivasan, N., Slingsby, C., & Jaenicke, R. (1994). Three‐dimensional model and quaternary structure of the human eye lens protein γS‐crystallin based on β‐and γ‐crystallin X‐ray coordinates and ultracentrifugation. Protein Science3(10), 1840-1846.
1994 Zarina, S., Abbasi, A., & Zaidi, Z. H. (1994). Cataractous lens and its environment. Pure and applied chemistry66(1), 111-115.
1992 Zarina, S., Abbasi, A., & Zaidi, Z. H. (1992). Primary structure of β s-crystallin from human lens. Biochemical Journal287(2), 375-381.
1987 Zarina, S., Zaidi, Z. H., & Wania, J. H. (1987). Free amino acids composition of aqueous humor from Pakistani subjects with senile cataract. J Pak Med Assoc37(3), 67-70.